We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App





Abbott Introduces GLP Systems Track Laboratory Automation Solution

By LabMedica International staff writers
Posted on 22 May 2023
Print article
Image: GLP Systems offers global scale and is trusted by more than 25 sites globally (Photo courtesy of Abbott)
Image: GLP Systems offers global scale and is trusted by more than 25 sites globally (Photo courtesy of Abbott)

Abbott (Lake Forest, IL, USA) is participating in EuroMedLab-WorldLab 2023 where it is introducing GLP Systems, an innovative total laboratory automation (TLA) solution, offering proven technology with more flexibility and options to meet high volume needs.

Clinical labs are constantly on the lookout for solutions that can help them process an increasing number of sample tubes more efficiently, while simultaneously reducing costs and maintenance of their systems. A significant objective is to facilitate connectivity with a diverse range of instruments, which would help reduce both complexity and cost, and most importantly, simplify the decision-making process regarding automation. The GLP TLA system, which employs an automated sample delivery track system, handles an impressive 900 samples per hour end-to-end. This automation significantly cuts down turnaround time, positively impacting patient care, especially in critical care units. The system also includes a feature that limits direct contact with patients' blood samples, thus safeguarding the workers. It enhances efficiency through consistent sample management, thereby ensuring a more reliable and speedier laboratory service.

The GLP TLA system can markedly boost the efficacy of laboratory testing. A standout feature of this system is its multi-floor transport capability, which eliminates the boundaries between various departments and floors, thereby expediting the availability of test results for doctors. The GLP TLA system mitigates the risks associated with implementing a long-term solution, thanks to its innovative track design. Labs now have the flexibility to modify their track to accommodate future changes and can optimize floor space by evolving their labs from a 2D to a 3D setup. The system also alleviates the common difficulties associated with adopting a new automation system by minimizing the time needed for track implementation and offering more efficient service and training. The GLP TLA system allows labs to concentrate on crucial tasks by maximizing uptime with infinite redundancy, streamlining workflow, and reducing turnaround time.

Related Links:
Abbott 

Flocked Swab
HydraFlock and PurFlock Ultra
New
Gold Supplier
HDL Subfractions Kit
Lipoprint HDL Subfractions Kit
New
Semi-Automatic Biochemistry Analyzer
CA-80
New
Semi-Automatic Coagulation Analyzer
Clot 2B

Print article

Channels

Clinical Chem.

view channel
Image: Electrochemical cells etched by laser on wooden tongue depressor measure glucose and nitrite in saliva (Photo courtesy of Analytical Chemistry)

Biosensor-Fabricated Wooden Tongue Depressor Measures Glucose and Nitrite in Saliva

Physicians often use tongue depressors to examine a patient's mouth and throat. However, it is hard to imagine that this simple wooden tool could actively assess a patient's health. This idea has led to... Read more

Hematology

view channel
Image: The Atellica HEMA 570 and 580 hematology analyzers remove workflow barriers (Photo courtesy of Siemens)

Next-Gen Hematology Analyzers Eliminate Workflow Roadblocks and Achieve Fast Throughput

Hematology testing is a critical aspect of patient care, utilized to establish a patient's health baseline, track treatment progress, or guide timely modifications to care. However, increasing constraints... Read more

Immunology

view channel
Image: Newly observed anti-FSP antibodies have also been found to predict immune-related adverse events (Photo courtesy of Calviri)

First Blood-Based Biomarkers Test to Predict Treatment Response in Cancer Patients

Every year worldwide, lung cancer afflicts over two million individuals and almost the same number of people succumb to the disease. This malignancy leads the charts in cancer-related mortalities, with... Read more

Microbiology

view channel
Image: The rapid MTB strip test for tuberculosis can identify TB patients within two hours (Photo courtesy of Chulalongkorn University)

Rapid MTB Strip Test Detects Tuberculosis in Less Than an Hour without Special Tools

Tuberculosis (TB), a highly infectious disease, continues to pose significant challenges to public health worldwide. TB is caused by a bacterium known as "Mycobacterium tuberculosis," spreading through... Read more

Pathology

view channel
Image: The UNIQO 160 (CE-IVDR) advances diagnostic analysis for autoimmune diseases (Photo courtesy of EUROIMMUN)

Novel Automated IIFT System Enables Cutting-Edge Diagnostic Analysis

A newly-launched automated indirect immunofluorescence test (IIFT) system for autoimmune disease diagnostics offers an all-in-one solution to enhance the efficiency of the complete IIFT process, comprising... Read more

Technology

view channel
Electronic biosensor uses DNA aptamers for detecting biomarkers in whole blood samples (Photo courtesy of Freepik)

Electronic Biosensor Detects Biomarkers in Whole Blood Samples without Addition of Reagents

The absence of robust, reliable, and user-friendly bioanalytical tools for early and timely diagnosis of cardiovascular diseases, particularly sudden cardiac arrest, leads to preventable deaths and imposes... Read more

Industry

view channel
Image: The Coris acquisition provides Avacta with a broad, professional-use rapid test product portfolio (Photo courtesy of Coris Bioconcept)

Avacta Expands Diagnostics Portfolio with Acquisition of Rapid Test Maker Coris Bioconcept

Avacta Group plc (London, UK), a life sciences company developing oncology drugs and diagnostics, has acquired Coris Bioconcept SRL (Gembloux, Belgium) for an upfront cash consideration of GBP 7.... Read more
Copyright © 2000-2023 Globetech Media. All rights reserved.